Syntometrine

Alliance Pharmaceuticals acquires rights to Novartis' Syntometrine obstetric drug
Pharmaceutical Business Review
Fri, 06/7/13 - 10:49 am
Alliance Pharma
Novartis
Syntometrine
obstetrics